- IONIS 486178, an antisense oligonucleotide optimised to target muscle cells (through coupling to an antibody) injected systemically, improves muscle damage in mice with DM1.
- Intracerebroventricular injection reduces behavioural impairment in treated mice.
- These results open up the possibility of intrathecal treatment in DM1.